Tizanidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 13 USDMF, 2 CEP/COS, 6 JDMF, 7 EU WC, 3 KDMF, 7 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 74 FDA Orange Book, 13 Europe, 2 Canada, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 8 DKSH, 1 Jai Radhe Sales, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 31 Direct Compression, 22 Controlled & Modified Release, 20 Thickeners and Stabilizers, 20 Granulation, 19 Disintegrants & Superdisintegrants, 15 Co-Processed Excipients, 13 Taste Masking, 11 Film Formers & Plasticizers, 10 Lubricants & Glidants, 9 Empty Capsules, 6 Chewable & Orodispersible Aids, 5 Topical, 5 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 3 Parenteral, 3 Solubilizers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 19 Finished Drug Prices

MARKET PLACE

9 APIs, 2 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 USP, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20397 / DOSAGE - TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TIZANIDINE HYDROCHLORIDE(UNII: B53E3NMY5C) (TIZANIDINE - UNII:6AI06C00GW)	TIZANIDINE	4mg

Inactive Ingredients

Ingredient Name	Acorda Therapeutics, Inc.	PD-Rx Pharmaceuticals, Inc.
ANHYDROUS LACTOSE(3SY5LH9PMK)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
GELATIN(2G86QN327L)
SILICON DIOXIDE(ETJ7Z6XBU4)
STEARIC ACID(4ELV7Z65AP)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Tizanidine Hydrochloride